Cited by 235Estrogen and related hormone effectsNeuroendocrine regulation and behaviorNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORY

Fink, George, Sumner, Barbara EH, McQueen, Judith K., Wilson, Helen, Rosie, Roberta·1998·Clinical and Experimental Pharmacology and Physiology

Abstract

SUMMARY: 1. Sex steroid hormones exert profound effects on mood and mental state. Thus, in women, oestrogen is thought to protect against depression and delay the onset of schizophrenia and Alzheimer's disease. 2. Our studies in the female rat show that oestradiol, in its positive feedback mode for gonadotrophin release, increases the expression of genes for the 5‐hydroxytryptamine 5‐HT 2A receptor and the serotonin transporter (SERT) in the dorsal raphe nucleus and the density of 5‐HT 2A receptor and SERT sites in regions of the forebrain that, in the human, are concerned with cognition, mental state, emotion and memory. 3. In the male rat, castration decreases while oestrogen and testosterone, but not 5α‐dihydrotestosterone (5α‐DHT), increase the density of 5‐HT 2A receptors in forebrain. The fact that 5α‐DHT has no effect suggests that the action of testosterone depends on its conversion to oestradiol by aromatase. 4. In intact rats, the density of 5‐HT 2A receptors in cerebral cortex is significantly higher in prooestrous female than in male and dioestrous female rats, showing that the spontaneous, preovulatory surge of oestradiol that reaches a peak at 12.00 h of pro‐oestrus also increases the density of 5‐HT ZA receptors in cortex. 5. Oestrogen and testosterone (by way of its conversion to oestrogen) also stimulate the expression of the arginine vasopressin gene in the bed nucleus of the stria terminalis of the rodent, a mechanism that plays a key role in olfactory memory. 6. These actions of sex steroid hormones are discussed in the context of genomic versus non‐genomic mechanisms, the recent discovery that there are two oestradiol receptors with different distributions in brain, the significance of our findings for our understanding of the control of mood, mental state and memory and the mechanism by which oestrogen stimulation of the 5‐HT 2A receptor could delay the onset of Alzheimer's disease.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.1998.tb02151.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 160

  1. 10.1113/expphysiol.1988.sp003145 · DOI
  2. 10.1098/rstb.1970.0056 · DOI
  3. 10.1016/S0079-6123(08)60779-7 · DOI
  4. 10.1007/978-1-4613-8084-9 · DOI
  5. 10.1016/0022-4731(88)90091-X · DOI
  6. 10.1016/0306-4522(88)90054-1 · DOI
  7. 10.1006/mcne.1993.1014 · DOI
  8. 10.1016/0002-9378(81)90417-8 · DOI
  9. Studd J., 1994, Premenstrual depression, Focus Depression, 2, 6
  10. 10.1136/bmj.307.6917.1471 · DOI
  11. 10.1192/bjp.139.2.128 · DOI
  12. 10.1192/bjp.164.4.513 · DOI
  13. 10.1016/S0889-8529(05)70247-4 · DOI
  14. 10.1192/bjp.167.2.163 · DOI
  15. 10.1016/1047-2797(94)90099-X · DOI
  16. 10.1136/bmj.313.7067.1229 · DOI
  17. Bäckström T., 1995, Symptoms related to the menopause and sex steroid treatments, Ciba Found. Symp., 191, 171
  18. Harlow BL, 1995, Association of medically treated depression and age at natural menopause, Am. J. Epidemiol., 141, 1170, 10.1093/oxfordjournals.aje.a117390 · DOI
  19. 10.1136/bmj.314.7085.977a · DOI
  20. 10.1159/000407529 · DOI
  21. 10.1016/S0306-4530(96)00023-6 · DOI
  22. 10.1016/0006-3223(94)00181-2 · DOI
  23. 10.1016/S0140-6736(96)91414-2 · DOI
  24. 10.1001/archpsyc.1979.01780050060006 · DOI
  25. Bleuler E., 1950, Dementia Praecox or the Group of Schizophrenias
  26. 10.1515/REVNEURO.1994.5.1.27 · DOI
  27. 10.1017/S0033291700026398 · DOI
  28. Kraepelin E., 1971, Dementia Praecox and Paraphrenia
  29. 10.1192/bjp.161.4.445 · DOI
  30. 10.1001/archpsyc.1984.01790130053007 · DOI
  31. 10.1007/BF02190244 · DOI
  32. 10.1093/schbul/16.2.185 · DOI
  33. Kaplan HI, 1985, Comprehensive Textbook of Psychiatry
  34. Bunney BG, 1995, Psychopharmacology: The Fourth Generation of Progress, 1205
  35. 10.1016/S0140-6736(05)64533-3 · DOI
  36. 10.1016/S0140-6736(96)03356-9 · DOI
  37. Paganini‐Hill A., 1994, Estrogen deficiency and risk of Alzheimer's disease in women. Am., J. Epidemiol., 140, 257
  38. 10.1093/oxfordjournals.aje.a117245 · DOI
  39. 10.1001/archneur.1994.00540210068014 · DOI
  40. Barrett‐Connor E., 1993, Estrogen replacement therapy and cognitive function in older women, JAMA, 269, 2637, 10.1001/jama.1993.03500200051032 · DOI
  41. 10.1159/000106929 · DOI
  42. Hagino N., 1994, Estrogen in cognitive behaviors: Clinical application of estrogen for dementia of Alzheimer‐type, Acta Biol. Hung., 45, 233
  43. 10.1523/JNEUROSCI.18-07-02550.1998 · DOI
  44. Jaffe AB, 1994, Estrogen regulates metabolism of Alzheimer amyloid P precursor protein, J. Biol. Chem., 269, 13065, 10.1016/S0021-9258(17)36796-0 · DOI
  45. 10.1210/endo.136.5.7720680 · DOI
  46. 10.1073/pnas.89.10.4668 · DOI
  47. Ashcroft GW, 1972, Modified amine hypothesis for the aetiology of affective illness, Lancet, 573
  48. 10.1136/bmj.314.7085.932 · DOI
  49. 10.1016/0091-3057(88)90215-8 · DOI
  50. 10.1111/j.1600-0773.1992.tb01629.x · DOI
  51. 10.1016/0024-3205(89)90384-6 · DOI
  52. Hrdina PD, 1995, Serotonergic markers in platelets of patients with major depression: Upregulation of 5‐HTi receptors, J Psychiatry Neurosci, 20, 11
  53. Sibille E., 1997, Antisense inhibition of 5‐hydroxytryptamine2A receptor induces an antidepressant‐like effect in mice, Mol. Pharmacol., 52, 1056, 10.1124/mol.52.6.1056 · DOI
  54. 10.1136/bmj.308.6940.1311 · DOI
  55. Janssen PA, 1988, Pharmacology of risperidone (R 64,766), a new antipsychotic with serotonin‐S2 and dopamine‐D2 antagonistic properties, J. Pharmacol. Exp. Ther., 244, 685
  56. Leysen JE, 1992, In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone, Mol. Pharmacol., 41, 494
  57. Meltzer HY, 1989, Classification of typical and atypical antipsychotic drugs on the basis of dopamine D‐1, D‐2 and serotonin pKi values, J. Pharmacol. Exp. Ther., 251, 238
  58. 10.1001/archpsyc.1993.01820220066007 · DOI
  59. Fink G., 1995, Serotonin in the Central Nervous System and Periphery, 175
  60. 10.1007/BF02088099 · DOI
  61. 10.1006/mcne.1993.1010 · DOI
  62. 10.1016/0960-0760(95)00075-B · DOI
  63. 10.1146/annurev.ph.41.030179.003035 · DOI
  64. 10.1038/383306a0 · DOI
  65. 10.1016/S0169-328X(98)00148-X · DOI
  66. 10.1016/S0304-3940(97)00651-4 · DOI
  67. 10.1016/S0306-4522(97)00445-4 · DOI
  68. 10.1016/0024-3205(83)90053-X · DOI · Paper page
  69. Sumner BEH, 1997, Testosterone or estrogen increases 5‐HT2A receptor density in male rat forebrain, Soc. Neurosci. Abstr., 23
  70. 10.1677/joe.0.0730157 · DOI
  71. 10.1677/joe.0.0730441 · DOI
  72. 10.1192/bjp.171.5.444 · DOI
  73. Meltzer CC, 1997, Age‐related decline in serotonin (5‐HT2A) receptors in humans as measured by positron emission tomography (PET) and [18F] altanserin, Soc. Neurosci. Abstr., 23, 1685
  74. 10.1016/S0925-4927(96)02806-5 · DOI
  75. 10.1097/00001756-199504190-00019 · DOI
  76. 10.3109/07853899309147869 · DOI
  77. 10.3109/01485018208990253 · DOI
  78. 10.1016/0378-5122(89)90003-0 · DOI
  79. 10.1210/jcem-64-1-68 · DOI
  80. 10.1111/j.1365-2265.1995.tb02669.x · DOI
  81. 10.1210/jcem-65-6-1118 · DOI
  82. 10.1172/JCI113412 · DOI · Paper page
  83. Vermeulen A., 1993, The male climacterium, Ann. Med., 25, 531, 10.1080/07853890.1993.12088579 · DOI
  84. 10.1289/ehp.93101s291 · DOI
  85. 10.1210/jc.81.10.3578 · DOI
  86. 10.1016/0002-9378(85)90001-8 · DOI
  87. 10.1006/frne.1994.1006 · DOI
  88. Zifa E., 1992, 5‐Hydroxytryptamine receptors, Pharmacol. Rev., 44, 401
  89. 10.1016/0306-4530(94)90019-1 · DOI
  90. Fink G., 1996, 5‐hydroxytryptamine2A receptor antagonists block the oestradiol‐17β‐induced surge of luteinizing hormone‐releasing hormone (LHRH) into hypophysial portal blood but do not affect LHRH synthesis, J. Physiol., 495, P117
  91. 10.1016/0091-3057(85)90477-0 · DOI
  92. James MD, 1989, Behavioral Pharmacology of 5‐HT, 73
  93. 10.1016/0024-3205(86)90272-9 · DOI
  94. Fink G., 1996, Molecular Mechanisms of Neuronal Communication: A Tribute to Nils‐Ake Hillarp, 177
  95. 10.1146/annurev.cb.10.110194.002105 · DOI
  96. Nitsch RM, 1994, Regulation of proteolytic processing of the amyloid beta‐protein precursor of Alzheimer's disease in transfected cell lines and in brain slices, J. Neural Transm. Suppl., 44, 21
  97. 10.1016/0306-4522(93)90241-7 · DOI
  98. Aghajanian GK, 1987, Psychopharmacology: The Third Generation of Progress, 141
  99. 10.1016/0006-8993(90)91199-Q · DOI · Paper page
  100. 10.1016/0014-2999(94)90502-9 · DOI
  101. 10.1016/S0028-3908(97)00051-8 · DOI
  102. 10.1016/0028-3908(83)90150-8 · DOI
  103. 10.1159/000123527 · DOI
  104. 10.1016/0306-4522(92)90202-D · DOI · Paper page
  105. 10.1016/0006-8993(93)90107-X · DOI
  106. Nauta WJH., 1963, Advances in Neuroendocrinology, 5
  107. 10.1016/S0169-328X(96)00233-1 · DOI
  108. Alheid GF, 1995, The Rat Nervous System, 495
  109. Ben‐Ari Y., 1981, The Amygdaloid Complex
  110. 10.1677/joe.0.1290099 · DOI
  111. Jakab RL, 1995, The Rat Nervous System, 405
  112. Aghajanian GK, 1978, Psychopharmacology: A Generation of Progress, 171
  113. Maes M., 1995, Psychopharmacology: The Fourth Generation of Progress, 933
  114. Fuller RW., 1985, Neuropharmacology of Serotonin, 1
  115. Briley M., 1985, Neuropharmacology of Serotonin, 50
  116. 10.1016/0014-2999(93)90833-4 · DOI
  117. 10.1016/0165-1781(88)90082-0 · DOI
  118. 10.1007/BF02246979 · DOI
  119. 10.1016/0165-1781(94)90034-5 · DOI
  120. 10.1001/archpsyc.1988.01800340045006 · DOI
  121. 10.1007/BF02412121 · DOI
  122. 10.1111/j.1476-5381.1995.tb15919.x · DOI
  123. 10.1016/0006-2952(74)90250-0 · DOI
  124. Hoyer D., 1994, International union of pharmacology classification of receptors for 5‐hydroxytryptamine (serotonin), Pharmacol. Rev., 46, 157
  125. Leysen JE, 1983, CNS Receptors: From Molecular Pharmacology to Behaviour, 373
  126. 10.1016/0304-3940(92)90668-W · DOI
  127. 10.1016/S0140-6736(96)90079-3 · DOI
  128. 10.1002/(SICI)1096-9861(19980216)391:1<322::AID-CNE12>3.0.CO;2-U · DOI
  129. 10.1073/pnas.93.12.5925 · DOI
  130. 10.1016/0014-5793(96)00782-X · DOI · Paper page
  131. Shughrue PJ, 1997, Comparative distribution of estrogen receptor‐a and ‐B mRNA in the rat central nervous system, J. Comp. Neurol., 388, 507, 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6 · DOI
  132. 10.1002/(SICI)1096-9861(19960617)370:1<71::AID-CNE7>3.0.CO;2-I · DOI
  133. 10.1006/frne.1995.1006 · DOI
  134. 10.1677/joe.0.1050163 · DOI
  135. 10.1126/science.2181662 · DOI
  136. 10.1074/jbc.272.21.13849 · DOI
  137. 10.1126/science.275.5296.86 · DOI
  138. 10.1016/B978-0-08-026864-4.50008-6 · DOI
  139. 10.1016/0361-9230(81)90111-8 · DOI
  140. 10.1007/BF00428689 · DOI
  141. 10.1016/0306-4530(77)90042-7 · DOI
  142. 10.1002/9780470513989 · DOI
  143. 10.1038/298270a0 · DOI
  144. Wilson JD, 1992, Williams Textbook of Endocrinology
  145. Naftolin F., 1975, The formation of estrogens by central neuroendocrine tissues, Recent Prog. Horm. Res., 31, 295
  146. 10.1016/0006-8993(88)90066-2 · DOI · Paper page
  147. Bluthé RM, 1993, Social recognition in mice is modulated by androgen‐dependent vasopressinergic and cholecystokininergic neurotransmission, Soc. Neurosci. Abstr., 19
  148. 10.1016/0306-4530(93)90028-J · DOI · Paper page
  149. Dantzer R., 1992, Vasopressin involvement in antipyresis, social communication and social recognition: A synthesis, Crit. Rev. Neurobiol., 6, 243
  150. 10.1210/endo-125-5-2335 · DOI · Paper page
  151. 10.1128/MCB.13.4.2342 · DOI
  152. 10.1016/S0959-437X(05)80280-1 · DOI
  153. 10.1006/mcne.1994.1034 · DOI
  154. 10.1210/endo.137.11.8895349 · DOI
  155. 10.1111/j.1469-185X.1984.tb00406.x · DOI
  156. 10.1210/edrv-4-4-363 · DOI
  157. 10.1017/S0021932000006787 · DOI
  158. 10.1017/S0033291700005572 · DOI
  159. 10.1017/S0033291700020407 · DOI
  160. 10.1038/32911 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Fink, G., Sumner, B. E., McQueen, J. K., Wilson, H., & Rosie, R.
Affiliations
University of Edinburgh (GB)
Corresponding author
Fink, George
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
1998-10
Volume
25
Issue
10
Pages
764-775
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2004623377
Cited by
235
References
3
Citations by year
2025: 2 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 8 · 2017: 4 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 7 · 2012: 8
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical and Experimental Pharmacology and Physiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
sex hormones, estradiol, testosterone, 5-HT2A receptor, serotonin transporter, dorsal raphe nucleus, castration, aromatase, vasopressin, bed nucleus of the stria terminalis, olfactory memory, Alzheimer's disease, depression, schizophrenia, mood, memory, oestradiol receptor, cerebral cortex
MeSH terms
Affect, Animals, Brain, Consciousness, Estrogens, Female, Humans, Male, Memory, Receptors, Serotonin, Serotonin, Gonadal Steroid Hormones, Testosterone, Receptor, Serotonin, 5-HT2A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review